Kimmel Heather L, O'Connor Joann A, Carroll F Ivy, Howell Leonard L
Division of Neuroscience, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, United States.
Pharmacol Biochem Behav. 2007 Jan;86(1):45-54. doi: 10.1016/j.pbb.2006.12.006. Epub 2006 Dec 20.
Although the behavioral-stimulant and reinforcing effects of cocaine and related psychomotor stimulants have been attributed to their actions at the dopamine transporter (DAT), the reinforcing effectiveness of these compounds varies. The properties that confer these differences are important considerations when developing agonist pharmacotherapies for the treatment of stimulant abuse. The present studies focused on the time course of action and pharmacological specificity of six 3-phenyltropane analogs of cocaine (RTI-112, RTI-126, RTI-150, RTI-171, RTI-177, and RTI-336) by observing their behavioral-stimulant, neurochemical, and reinforcing effects in squirrel monkeys. The faster-onset analogs (RTI-126, RTI-150, and RTI-336), and one of the slower-onset DAT selective analogs (RTI-177 and RTI-171) produced behavioral-stimulant effects, while the slower-onset nonselective analog RTI-112 did not. The time to the peak behavioral-stimulant effect and the peak caudate dopamine levels was strongly correlated, but the area under the curve of the time course of behavioral-stimulant effect and dopamine levels was not correlated. These results suggest that the rate of onset plays a more important role than duration of action in the stimulant effect of these analogs. In addition, the slower-onset nonselective analog (RTI-112) clearly did not exhibit any reinforcing effects while the faster-onset nonselective (RTI-126) and all the DAT-selective analogs showed robust reinforcing effects (RTI-150, and RTI-177) or showed trends towards reinforcing effects (RTI-336 and RTI-171). Hence, there was a general trend for compounds that had a faster onset and/or DAT selectivity to produce significant behavioral-stimulant and reinforcing effects.
尽管可卡因及相关精神运动兴奋剂的行为刺激和强化作用被认为是其作用于多巴胺转运体(DAT)所致,但这些化合物的强化效果各不相同。在开发用于治疗兴奋剂滥用的激动剂药物疗法时,赋予这些差异的特性是重要的考虑因素。本研究通过观察六种可卡因的3-苯基托烷类似物(RTI-112、RTI-126、RTI-150、RTI-171、RTI-177和RTI-336)在松鼠猴身上的行为刺激、神经化学和强化作用,聚焦于其作用的时间进程和药理学特异性。起效较快的类似物(RTI-126、RTI-150和RTI-336),以及起效较慢的DAT选择性类似物之一(RTI-177和RTI-171)产生了行为刺激作用,而起效较慢的非选择性类似物RTI-112则没有。行为刺激效应峰值和尾状核多巴胺水平峰值出现的时间密切相关,但行为刺激效应和多巴胺水平随时间变化曲线下的面积并无相关性。这些结果表明,起效速度在这些类似物的刺激效应中比作用持续时间发挥着更重要的作用。此外,起效较慢的非选择性类似物(RTI-112)明显未表现出任何强化作用,而起效较快的非选择性类似物(RTI-126)以及所有DAT选择性类似物则表现出强烈的强化作用(RTI-150和RTI-177)或有强化作用的趋势(RTI-336和RTI-171)。因此,一般趋势是起效较快和/或具有DAT选择性的化合物会产生显著的行为刺激和强化作用。